Search > Addiction
My employer runs this trial

Screening and Treatment System for Opiate Dependence

(C-DOSETaP Trial)

NS
NC
Overseen ByNeeraj Chhabra, MD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
Disqualifiers: Children younger than 16
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system.

The main questions this study aims to answer are:

1. Does the C-DOSETaP System increase screening for patients with OUD;

2. Does the C-DOSETaP System improve continuity of health care for patients with OUD;

3. Does the C-DOSETaP System increase use of medications for opioid use disorder; and

4. Does the C-DOSETaP System reduce the number of opioid-related deaths in the neighborhoods served.

Who Is on the Research Team?

NS

Niranjan S. Karnik, MD, PhD

Principal Investigator

UIC, College of Medicine

NC

Neeraj Chhabra, MD

Principal Investigator

UIC, College of Medicine

Are You a Good Fit for This Trial?

Inclusion Criteria

Participant must be a patient seen at the University of Illinois Hospital and Clinics
I am 16 years old or older.

Exclusion Criteria

I am younger than 16 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

12 months
Ongoing screening across health system

Engagement and Treatment

Implementation of the C-DOSETaP system to improve healthcare engagement and utilization of OUD treatments

12 months
Regular engagement through clinical workflows

Follow-up

Participants are monitored for continuity of care and MOUD utilization

12 months
Follow-up appointments and referrals

Data Analysis and Reporting

Analysis of screening rates, continuity of care, and MOUD utilization, with reporting to health authorities

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • C-DOSETaP System

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Patients with OUDExperimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.